Article
Using Aspergillus nidulans to identify antifungal drug resistance mutations.
Eukaryotic cell - 1 Feb 2014
He Xiaoxiao, Li Shengnan, Kaminskyj Susan G W
Abstract excerpt
Systemic fungal infections contribute to at least 10% of deaths in hospital settings. Most antifungal drugs target ergosterol (polyenes) or its biosynthetic pathway (azoles and allylamines), or beta-glucan synthesis (echinocandins). Antifungal drugs that target proteins are prone to the emergence of resistant strains. Identification of genes whose mutations lead to targeted resistance can provide new information...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
